TET 3 and BRCA 1 co-repress EZH 2 to inhibit the aggressive behavior of breast cancer cells

Mingxin Wang,Qifeng Yang,Qingzhong Yuan,Xinhao Yi,Qi Wang,Panli Tan,Guoqiang Li

2016-01-01

Abstract:The functions of Ten-eleven translocation 3 (TET3) in breast cancer are still unclear. Here, we reported that TET3 was downregulated in highly metastatic breast cancer cell lines such as MDA-MB-231 cells and MDA-MB-453 cells compared with non-metastatic MCF-7 cells and T47D cells. In 32 breast cancer clinical samples, the expression of TET3 was reduced in lymph node metastatic tissues compared with primary tumor tissues. Moreover, knockdown of TET3 in breast cancer cell lines increased the proliferation and invasion of breast cancer cells. Furthermore, we shown that TET3 protein expression was increased by co-expression with BRCA1, and BRCA1 could stabilize the TET3 protein level. We declared the mechanism that TET3 could bind to the EZH2 promoter and negatively regulates EZH2 transcription. Finally, we revealed TET3 and BRCA1 negatively regulated breast cancer cells aggressive behavior through the inhibition of EZH2. Taken together, these findings indicated that TET3 may contribute to the inhibition of breast cancer proliferation and metastasis through the EZH2 repression.